CONTRALATERAL BREAST CANCER

CONTRALATERAL BREAST CANCER was reported 206 times

CONTRALATERAL BREAST CANCER is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Estrogen [EPC] 165 0.0009
1 Progesterone [EPC] 6 0.0003
2 Aromatase Inhibitor [EPC] 15 0.0001
3 HER2/neu Receptor Antagonist [EPC] 6 0.0001
4 Androgen [EPC] 2 0.0001
5 Bile Acid [EPC] 1 0.0000
6 Histamine-1 Receptor Antagonist [EPC] 1 0.0000
7 Parathyroid Hormone Analog [EPC] 1 0.0000
8 Alkylating Drug [EPC] 2 0.0000
9 Leukocyte Growth Factor [EPC] 1 0.0000
10 Calcium [EPC] 1 0.0000
11 Aldosterone Antagonist [EPC] 1 0.0000
12 Angiotensin 2 Receptor Blocker [EPC] 2 0.0000
13 Microtubule Inhibitor [EPC] 1 0.0000
14 RANK Ligand Inhibitor [EPC] 1 0.0000
15 Thiazide Diuretic [EPC] 1 0.0000
16 Platinum-based Drug [EPC] 1 0.0000
17 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
18 Osmotic Laxative [EPC] 1 0.0000
19 beta-Adrenergic Blocker [EPC] 1 0.0000
20 Loop Diuretic [EPC] 1 0.0000
21 Thalidomide Analog [EPC] 1 0.0000
22 Proton Pump Inhibitor [EPC] 1 0.0000
23 Corticosteroid [EPC] 1 0.0000
24 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000